Trademarkia Logo

Canada

C$
CYAXXVI
FORMALIZED

on 11 Dec 2024

Last Applicant/ Owned by

Renibus Therapeutics, Inc.

181 Grand Ave, Suite 225Southlake TX 76092

US

Serial Number

2367780 filed on 5th Jun 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

CYAXXVI

Trademark usage description

pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of c Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, pharmaceutical preparations for aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement.


Classification kind code

12

Mark Details


Serial Number

2367780

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 7th Jan 2025
Agent Changed
Submitted for opposition 257
on 12th Dec 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 11th Dec 2024
Created
Submitted for opposition 31
on 11th Dec 2024
Formalized
Submitted for opposition 30
on 5th Jun 2024
Filed
Submitted for opposition 228
on 5th Jun 2024
International Registration